HRP20050945B1 - Sustav za primjenu lijeka - Google Patents
Sustav za primjenu lijekaInfo
- Publication number
- HRP20050945B1 HRP20050945B1 HRP20050945AA HRP20050945A HRP20050945B1 HR P20050945 B1 HRP20050945 B1 HR P20050945B1 HR P20050945A A HRP20050945A A HR P20050945AA HR P20050945 A HRP20050945 A HR P20050945A HR P20050945 B1 HRP20050945 B1 HR P20050945B1
- Authority
- HR
- Croatia
- Prior art keywords
- drug
- filled
- delivery system
- drug delivery
- thermoplastic polymer
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229920001169 thermoplastic Polymers 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000010410 layer Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000011229 interlayer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Abstract
Predmetni izum pruža sustav za primjenu lijeka koji uključuje barem jedan odjeljak koji se sastoji od (i) termoplastične polimerne jezgre napunjene s lijekom, (ii) termoplastičnog polimernog međusloja napunjenog s lijekom i (iii) termoplastičnog polimernog ovoja koji ne sadrži lijek te prekriva međusloj, pri čemu je spomenuti međusloj napunjen s (a) kristalima prvog farmaceutski aktivnog spoja i s (b) drugim farmaceutski aktivnim spojem u otopljenom obliku, i gdje je spomenuta jezgra napunjena sa spomenutim drugim spojem u otopljenom obliku.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47305503P | 2003-05-23 | 2003-05-23 | |
EP03101490 | 2003-05-23 | ||
PCT/EP2004/050850 WO2004103336A2 (en) | 2003-05-23 | 2004-05-19 | Drug delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20050945A2 HRP20050945A2 (en) | 2006-02-28 |
HRP20050945B1 true HRP20050945B1 (hr) | 2014-03-14 |
Family
ID=36701594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20050945AA HRP20050945B1 (hr) | 2003-05-23 | 2005-11-04 | Sustav za primjenu lijeka |
Country Status (30)
Country | Link |
---|---|
US (3) | US8333983B2 (hr) |
EP (1) | EP1631255B1 (hr) |
JP (1) | JP4685780B2 (hr) |
KR (1) | KR101116267B1 (hr) |
CN (1) | CN1794974B (hr) |
AR (1) | AR044547A1 (hr) |
AU (1) | AU2004241747B2 (hr) |
BR (1) | BRPI0410455B8 (hr) |
CA (1) | CA2524665C (hr) |
CO (1) | CO5630021A2 (hr) |
CY (1) | CY1113500T1 (hr) |
DK (1) | DK1631255T3 (hr) |
EC (1) | ECSP056250A (hr) |
ES (1) | ES2396100T3 (hr) |
HK (1) | HK1084337A1 (hr) |
HR (1) | HRP20050945B1 (hr) |
IL (1) | IL171622A (hr) |
IS (1) | IS2864B (hr) |
MX (1) | MXPA05012595A (hr) |
NO (1) | NO336456B1 (hr) |
NZ (1) | NZ543652A (hr) |
PE (1) | PE20050815A1 (hr) |
PL (1) | PL1631255T3 (hr) |
PT (1) | PT1631255E (hr) |
RU (1) | RU2340344C2 (hr) |
SI (1) | SI1631255T1 (hr) |
TW (1) | TWI336627B (hr) |
UA (1) | UA84287C2 (hr) |
WO (1) | WO2004103336A2 (hr) |
ZA (1) | ZA200509450B (hr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8110211B2 (en) * | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
UA94118C2 (ru) | 2006-11-20 | 2011-04-11 | Н.В. Органон | Спиральная система введения лекарства |
JP2010510290A (ja) * | 2006-11-22 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | ミルタザピンのための膣送達系 |
TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
EP2062568A1 (en) * | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Oy | Vaginal delivery system |
WO2009141309A1 (en) * | 2008-05-20 | 2009-11-26 | N.V. Organon | Delivery system for paliperidone |
ES2344673B1 (es) * | 2008-08-07 | 2011-05-03 | Italfarmaco, S.A. | Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral. |
FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
WO2010077096A2 (ko) * | 2008-12-31 | 2010-07-08 | 한올바이오파마주식회사 | 약물전달기구 |
WO2010105995A2 (en) | 2009-03-17 | 2010-09-23 | Intervet International B.V. | Zoo-technical drug delivery device |
BR112012001353B8 (pt) * | 2009-07-21 | 2021-05-25 | The Population Council Inc | anel vaginal, e, método para fabricar um anel vaginal |
CA2798034A1 (en) * | 2010-03-28 | 2011-10-13 | Evestra, Inc. | Intravaginal drug delivery device |
US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
AU2012283837B2 (en) * | 2011-07-20 | 2017-04-27 | Patrick F. Kiser | Intravaginal devices for drug delivery |
HRP20211377T1 (hr) | 2011-11-23 | 2022-01-07 | Therapeuticsmd, Inc. | Prirodne kombinirane hormonske supstitucijske formulacije i terapije |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
WO2015086489A1 (en) | 2013-12-11 | 2015-06-18 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
US10413504B2 (en) * | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
CN109069526A (zh) * | 2016-05-12 | 2018-12-21 | 默沙东公司 | 用于递送抗病毒剂的药物递送系统 |
US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
CA3080325A1 (en) | 2017-10-27 | 2019-05-02 | Renovia Inc. | Devices, systems, and methods for training pelvic floor muscles |
US11690806B2 (en) | 2018-05-24 | 2023-07-04 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
SG11202005947RA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
US20200179274A1 (en) * | 2018-12-11 | 2020-06-11 | Lupin Inc. | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof |
KR102159904B1 (ko) | 2020-04-24 | 2020-09-24 | 강경원 | 약물 방출 고리를 구비한 월경컵 |
EP4215181A1 (en) * | 2022-01-21 | 2023-07-26 | Sever Pharma Solutions | An intravaginal ring |
WO2023200974A1 (en) * | 2022-04-14 | 2023-10-19 | Yale University | Nanoparticles and nanoparticle-releasing vaginal rings |
WO2024030116A1 (en) * | 2022-08-01 | 2024-02-08 | Lupin Inc. | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
EP0303306A1 (en) * | 1987-08-08 | 1989-02-15 | Akzo N.V. | Contraceptive implant |
WO1997002015A1 (en) * | 1995-07-04 | 1997-01-23 | Akzo Nobel N.V. | Ring-shaped devices |
EP0876815A1 (en) * | 1997-04-11 | 1998-11-11 | Akzo Nobel N.V. | "Drug delivery system for two or more active substances" |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US3995634A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
US3995633A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US4237885A (en) | 1978-10-23 | 1980-12-09 | Alza Corporation | Delivery system with mated members for storing and releasing a plurality of beneficial agents |
DE3040978A1 (de) | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
US4629449A (en) * | 1982-07-29 | 1986-12-16 | Alza Corporation | Vaginal dispenser for dispensing beneficial hormone |
EP0162492B1 (en) * | 1984-04-11 | 1989-08-02 | Thiemann Arzneimittel GmbH | Dosage units for controlled release of active material |
US4596576A (en) | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
US5766632A (en) * | 1993-10-01 | 1998-06-16 | Legere Pharmaceuticals, Ltd. | Method of using lectins for contraception |
JP3720386B2 (ja) * | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
US5972372A (en) | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
DE69817017T2 (de) | 1997-12-12 | 2004-02-26 | Akzo Nobel N.V. | Verpackung für einen vaginalring |
US6579533B1 (en) * | 1999-11-30 | 2003-06-17 | Bioasborbable Concepts, Ltd. | Bioabsorbable drug delivery system for local treatment and prevention of infections |
CA2442281C (en) * | 2001-03-27 | 2010-06-08 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
WO2003000156A1 (en) * | 2001-06-22 | 2003-01-03 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants |
PL367961A1 (en) * | 2001-08-31 | 2005-03-07 | Schering Oy | Drug delivery system |
-
2004
- 2004-05-03 TW TW093112401A patent/TWI336627B/zh not_active IP Right Cessation
- 2004-05-19 KR KR1020057022407A patent/KR101116267B1/ko active IP Right Grant
- 2004-05-19 CN CN2004800142223A patent/CN1794974B/zh active Active
- 2004-05-19 AU AU2004241747A patent/AU2004241747B2/en active Active
- 2004-05-19 NZ NZ543652A patent/NZ543652A/en not_active IP Right Cessation
- 2004-05-19 MX MXPA05012595A patent/MXPA05012595A/es active IP Right Grant
- 2004-05-19 US US10/558,040 patent/US8333983B2/en active Active
- 2004-05-19 WO PCT/EP2004/050850 patent/WO2004103336A2/en active Application Filing
- 2004-05-19 RU RU2005140277/15A patent/RU2340344C2/ru active
- 2004-05-19 ES ES04741599T patent/ES2396100T3/es active Active
- 2004-05-19 DK DK04741599.7T patent/DK1631255T3/da active
- 2004-05-19 SI SI200431986T patent/SI1631255T1/sl unknown
- 2004-05-19 EP EP04741599A patent/EP1631255B1/en active Active
- 2004-05-19 PL PL04741599T patent/PL1631255T3/pl unknown
- 2004-05-19 JP JP2006530206A patent/JP4685780B2/ja active Active
- 2004-05-19 CA CA2524665A patent/CA2524665C/en active Active
- 2004-05-19 PT PT47415997T patent/PT1631255E/pt unknown
- 2004-05-19 BR BRPI0410455A patent/BRPI0410455B8/pt active IP Right Grant
- 2004-05-19 UA UAA200510424A patent/UA84287C2/uk unknown
- 2004-05-21 AR ARP040101763A patent/AR044547A1/es not_active Application Discontinuation
- 2004-05-21 PE PE2004000522A patent/PE20050815A1/es not_active Application Discontinuation
-
2005
- 2005-10-24 IS IS8086A patent/IS2864B/is unknown
- 2005-10-27 IL IL171622A patent/IL171622A/en not_active IP Right Cessation
- 2005-11-03 NO NO20055171A patent/NO336456B1/no not_active IP Right Cessation
- 2005-11-04 HR HRP20050945AA patent/HRP20050945B1/hr not_active IP Right Cessation
- 2005-11-18 CO CO05117347A patent/CO5630021A2/es active IP Right Grant
- 2005-11-22 ZA ZA200509450A patent/ZA200509450B/en unknown
- 2005-12-23 EC EC2005006250A patent/ECSP056250A/es unknown
-
2006
- 2006-06-12 HK HK06106692.2A patent/HK1084337A1/xx not_active IP Right Cessation
-
2012
- 2012-11-09 US US13/672,804 patent/US8900615B2/en active Active
- 2012-11-09 US US13/673,162 patent/US8858977B2/en active Active
- 2012-12-21 CY CY20121101258T patent/CY1113500T1/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
EP0303306A1 (en) * | 1987-08-08 | 1989-02-15 | Akzo N.V. | Contraceptive implant |
WO1997002015A1 (en) * | 1995-07-04 | 1997-01-23 | Akzo Nobel N.V. | Ring-shaped devices |
EP0876815A1 (en) * | 1997-04-11 | 1998-11-11 | Akzo Nobel N.V. | "Drug delivery system for two or more active substances" |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050945B1 (hr) | Sustav za primjenu lijeka | |
MY163892A (en) | Drug delivery system | |
ATE378042T1 (de) | Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln | |
WO2007103557A3 (en) | Coating capsules with active pharmaceutical ingredients | |
WO2005042049A3 (en) | Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices | |
WO2006023644A3 (en) | Transdermal drug delivery device with translucent protective film | |
DE60132077D1 (de) | Vitaminzusammenstellung mit verzögerter freigabe | |
ATE216220T1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
ATE493115T1 (de) | Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum | |
DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
DK1194133T3 (da) | Aktivmiddelholdig mangelagsfilm ufgjort af in situ tværbundne hydrofile polymerer | |
NO20035645D0 (no) | Forsterket medikamentlevering i transdermale systemer | |
EP2258347A3 (en) | Tamper-resistant products for opioid delivery | |
UY27532A1 (es) | Forma de dosificación de liberación controlada dual. | |
WO2003082207A3 (en) | Volume efficient controlled release dosage form | |
EP1653897A4 (en) | TRANSDERMALES PLASTER WITH ACTIVE MIGRATION BARRIER LAYER | |
WO2005025549A3 (en) | Multi-layer transdermal drug delivery device | |
CO6321222A2 (es) | Una forma de dosificacion unitaria que comprende una matriz de pelicula delgada soluble en agua (oblea) que contiene un ingrediente activo | |
DE60320661D1 (de) | System mit kontrollierter freisetzung bioaktiver wirkstoffe | |
ATE466008T1 (de) | P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält | |
WO2007057762A3 (en) | Osmotic bi-layer tablet | |
WO2003057278A3 (en) | Drug delivery system for sustained delivery of glipizide | |
ATE535235T1 (de) | Galanthamin-haltiges arzneimittel mit kontrollierter freisetzung | |
WO2008081590A1 (ja) | 医療用組成物 | |
UY28624A1 (es) | Compuesto y forma de dosificación que comprende una mólecula anfifilica como vehiculo de suspensión |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
PPPP | Transfer of rights |
Owner name: N.V. ORGANON, NL |
|
PPPP | Transfer of rights |
Owner name: MSD OSS B.V., NL |
|
PPPP | Transfer of rights |
Owner name: MERCK SHARP & DOHME B.V., NL |
|
PPPP | Transfer of rights |
Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20160503 Year of fee payment: 13 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20170519 |